All Episodes
CME/CE — 22 episodes
Safety in oHCM Therapy: How and When to Transition Treatment?
Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
Cracking the Code of Obstruction: Unmet Needs in oHCM
When ß-Blockers Fall Short in oHCM: Time for a New Approach?
Molecular Precision: How Myosin Inhibitors Redefine Control
Redefining oHCM Care: Efficacy and Safety of Myosin Inhibitors
From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
Shifting the Script: Personalizing Overactive Bladder Treatment in Complex Patients
Test Your Skills and Learn From Experts on Best Practice in Diagnosis and Management of Systemic Mastocytosis
Hitting the Target in Atopic Dermatitis: Interdisciplinary Team Training for Leveraging IL-13 Inhibitors to Address the Burden of Disease
Decoding EGPA: A Clinical Deep Dive Into Diagnosis and Treatment
Future-Proofing in HAE: Advances in Long-term Prophylaxis to Prevent Attacks and Improve Quality of Life
Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
Chairperson's Perspective: Novel Treatments for Newly Diagnosed Ph+ CML-CP: Striking the Balance of Treatment With Patient Goals and QoL
Improving Outcomes and Addressing Racial Disparities in Patients With HR+/HER2- Early Breast Cancer: A Case-Based Learning Lab
Expert Answers to Common Questions on Response Matters: Transforming the Standard of Care in CML by Mastering Response-Guided Treatment
Chairperson’s Perspective: CDK 4/6 Inhibitors: Practice-Changing Implications of Targeted Therapies in HR+/HER2- Breast Cancer
Expert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC
Improved Outcomes in mCRPC with PSMA-Directed Diagnostics and Therapies
Evolving Perspectives in PIK3CA-related Overgrowth Spectrum Diagnosis & Treatment